Despite technology fostering a new generation of health care delivery, experts believe rural health solutions should be ...
Medicaid coverage of obesity-labeled GLP-1 receptor agonists may substitute for, rather than simply add to, diabetes-labeled ...
Nationwide nested case-control data showed current oral hormone therapy increased VTE (HR 1.6), ischemic stroke (HR 1.3), and ...
Community pharmacists offer accessible care, improve medication adherence, and build trust through education, vaccination ...
Clinicians break down HIV PrEP, its near-99% protection, and who’s missing out—women, youth, and Southern communities in PrEP ...
Tozorakimab (MEDI3506) met its primary and key secondary end points in the Phase 3 OBERON ( NCT05166889) and TITANIA ( ...
Vaccination and natural infection both train the immune system, but only one route carries the added risk of long COVID and ...
Lean-mass changes should be interpreted with performance endpoints, including handgrip strength, rather than isolated ...
Documentation limitations were the most frequently identified theme and included the absence of structured menopause-specific ...
Menopausal hormone therapy (MHT) initiated during perimenopause or early postmenopause was associated with a 22% reduction in cardiovascular disease (CVD) risk among women with va ...
Enrolled participants were predominantly vertically infected, long-term suppressed adolescents; dosing transitioned from initial injections to maintenance every 8 weeks, with median follow-up ...
As The Guardian reports, Goldman is an infectious disease expert with decades of experience in his field, and throughout his entire career, he’s only seen 2 measles cases, and none in almost 35 years.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results